AGL
agilon health, inc.0.6685
+0.0054+0.81%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Q&A clarifies trends, reaffirms guide
Q&A largely reaffirmed prepared remarks on agilon's 2026 breakeven path, but offered color on 2025's elevated cost trends from Q3 inpatient spikes—including $6.5 million in multimillion-dollar claims—pushing Q4 reserves to 7.4% for a full-year 6.5%. Management flagged more OpEx cuts via AI and automation, minimal unlinked coding exposure under the CMS notice (offsetting normalization like V28 via pathways), and broad-based payer exits over single-partner woes. No walk-backs; analysts' trend and 2027 rate probes drew confident nods to ongoing levers. Execution details matter for the thesis. Watch cost discipline.
Key Stats
Market Cap
277.15MP/E (TTM)
-Basic EPS (TTM)
-0.78Dividend Yield
0%Recent Filings
10-K
FY2025 results
agilon health's FY2025 results showed revenue declining 2% to $5.93B amid 3% MA membership drop to 511,000, driven by prior-year partnership exits, while CMS ACO beneficiaries fell 13% to 114,000. Q4 bore the brunt as medical services expense rose 2%—fueled by 5% higher per-member costs from elevated trends—flipping gross profit to a $160M loss, with medical margin cratering to negative $56.6M from $205M prior year. Platform costs held steady at 3% of revenue; impairments hit $36M on goodwill/intangibles. Cash burned $106M operationally; debt refinanced post-year-end. NYSE non-compliance looms absent reverse split approval. Physician partner documentation gaps risk payor audits.
8-K
Q4 results, 2026 breakeven guide
Agilon health reported Q4 2025 revenue of $1.57B, up 3% YoY, yet posted a $296M full-year Adjusted EBITDA loss amid membership drop to 625,000 from market exits. Medical margin swung to negative $57M for the year. 2026 guidance eyes breakeven Adjusted EBITDA midpoint with $5.5B revenue. Losses widened sharply.
8-K
Credit maturity extended to 2028
Agilon health extended its credit agreement maturity from February 18, 2026 to February 18, 2028, while trimming revolving commitments from $100M to $90M and mandating $50M minimum daily cash with the agent. Covenants tightened—dividends now hinge on two straight positive EBITDA quarters post-amendment—yet the two-year runway bolsters liquidity amid tight terms. Lenders repaid a non-consenting holdout.
8-K
CFO equity retention boosted
agilon health amended CFO Jeffrey Schwaneke's employment agreement effective January 1, 2026, granting a one-time 600,000 RSU award vesting over three years and $3.75M in FY2026 equity. Severance covers 12 months' pay and bonus if terminated without cause before mid-2027; equity vests through despite later exit. Retention locked in.
8-K
NYSE noncompliance notice
IPO
Website
Employees
Sector
Industry
AAGH
America Great Health
0.00+0.00
ADUS
Addus HomeCare Corporation
113.49-1.65
ALHC
Alignment Healthcare, Inc.
20.03-0.08
ASTH
Astrana Health Inc.
22.31+0.01
EHSI
Elite Health Systems, Inc.
1.31-0.14
INNV
InnovAge Holding Corp.
5.55-0.27
LWSCF
Sienna Sr Living Inc.
14.66+0.02
PIII
P3 Health Partners Inc.
4.59-0.36
PNTG
The Pennant Group, Inc.
29.73+0.00
SNDA
Sonida Senior Living, Inc.
31.53-0.06